Bionor Pharma Announces Filing of International Patent Application for its HIV Vaccine Vacc-HIV
Oslo, 11.06.2013 – Bionor Pharma ASA (OSE: BIONOR) announced today that it has filed an International Patent Application for its HIV Vaccine, Vacc-HIV. This application gives Bionor Pharma the opportunity to obtain patent protection for Vacc-HIV in all the major international pharmaceutical markets. Vacc-HIV, which is currently in the preclinical stage of development, is a …